
Sign up to save your podcasts
Or


This episode of Essential unpacks FDA confusion, California’s latest compounding curveball, and pharma-fueled myths about GLP-1s. We spotlight APC’s advocacy wins on Capitol Hill and why pharmacy tours pack political punch. Plus, the FDA’s eyebrow-raising move to reclassify natural thyroid products — and why it matters for patients everywhere.
By Pharmacy Podcast Network4.7
168168 ratings
This episode of Essential unpacks FDA confusion, California’s latest compounding curveball, and pharma-fueled myths about GLP-1s. We spotlight APC’s advocacy wins on Capitol Hill and why pharmacy tours pack political punch. Plus, the FDA’s eyebrow-raising move to reclassify natural thyroid products — and why it matters for patients everywhere.

16,778 Listeners

13,604 Listeners

3,082 Listeners

732 Listeners

1,333 Listeners

4,916 Listeners

35,689 Listeners

47,767 Listeners

1,408 Listeners

34 Listeners

7,511 Listeners

20,203 Listeners

933 Listeners

11 Listeners

5 Listeners